Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Fusion Pharmaceuticals

Request full access

Targeted alpha therapeutics (TAT) for the treatment of chemotherapy resistant cancers

Hamilton, CanadaFounded 2014Biotech & Life Sciences

About Fusion Pharmaceuticals

Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing next-generation precision medicines for cancer treatment. The company operates in the biopharmaceutical market, focusing on creating innovative radiotherapeutics that target multiple tumor types. Fusion Pharmaceuticals serves cancer patients and healthcare providers, aiming to improve patient outcomes and quality of life. The business model revolves around research and development, leveraging proprietary linker technology to enhance the safety and efficacy of their treatments. Revenue is generated through partnerships, licensing agreements, and eventual commercialization of their therapeutic products. The company is a spin-out from the Centre for Probe Development and Commercialization (CPDC), which provides it with a robust supply chain and extensive expertise in manufacturing. Fusion Pharmaceuticals is committed to pushing the boundaries of science to offer revolutionary cancer treatments.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2020

Fusion Pharmaceuticals in the Hamilton ecosystem

Live from Dealroom

The Fusion Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

19 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • FACIT (Fight Against Cancer Innovation Trust)

Series A12 investors entered at this stage

  • Johnson & Johnson Development Corporation
  • Johnson & Johnson Innovation
  • TPG Biotech
  • Genesys Capital
  • HealthCap
  • Varian Medical Systems
  • Adams Street Partners
  • Seroba Life Sciences
  • OrbiMed
  • Pivotal Life Sciences
  • Rock Springs Capital
  • Perceptive Advisors

Series B and later6 investors entered at this stage

  • Perceptive Advisors
  • Rock Springs Capital
  • Pivotal Life Sciences
  • McMaster University
  • OrbiMed
  • Centre For Probe Development And Commercialization
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Fusion Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.